Welcome
Support Centre
22 May 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ ...Back to search results ] [ Print-friendly version ]
Evaluation of Dutch Integrated Stroke Service Experiments
ISRCTN ISRCTN67636203
ClinicalTrials.gov identifier
Public title Evaluation of Dutch Integrated Stroke Service Experiments
Scientific title
Acronym EDISSE
Serial number at source N/A
Study hypothesis Stroke services lead to better and more effective, efficient and patient-directed care for stroke patients compared to usual care.
Lay summary Not provided at time of registration
Ethics approval Approvals received from Local Medical Ethics Committees for all six regional services at all hospitals involved between May and September 1999.

Case regions:
1. Heemstede, Spaarne Hospital: Medical Ethics Committee of Spaarne Hospital
2. Delft, Hospital Reinier de Graaf Groep: Medical Ethics Committee for South West Holland
3. Nijmegen, Canisius Wilhelmina Hospital: Ethics Committee of Canisius

Control regions:
1. Amsterdam, Saint Lucas Andreas Hospital: Medical Ethics Committee of Saint Lucas Andreas Hospital
2. Hilversum, Hilversum Hospital: Medical Ethics Committee of Hilversum Hospital
3. Leiderdorp, Rijnland Hospital: Medical Ethics Committee of Rijnland Hospital

Central registration:
1. Central Committee for Patient-Related Research: annual reports and overviews of decisions by local MECs
2. The Central Committee on Research Involving Human Subjects (CCMO)
Study design Prospective, non-randomized controlled trial.
Countries of recruitment Netherlands
Disease/condition/study domain Ischemic stroke
Participants - inclusion criteria All patients in these experimental settings were compared to similar concurrent patients from general hospitals in three other Dutch regions. The latter were selected from a group of 23 hospitals participating in a previous national study. Based on the data collected in this already completed study, three hospitals were selected as representing the average Dutch patient, receiving the average current level of Dutch stroke care. The criteria for this selection were:
1. The average age of patients
2. Duration of hospital stay
3. Case-fatality
4. Barthel Index at discharge
5. Destination after discharge

All consecutive hospital patients admitted in a region with an acute first or recurrent ischemic stroke or Transient Ischemic Attack (TIA) were included.
Participants - exclusion criteria Dead on arrival.
Anticipated start date 01/09/1999
Anticipated end date 31/05/2000
Status of trial Completed
Patient information material
Target number of participants A minimum of 75 and a maximum of 100 patients per cluster; 411 patients were registered.
Interventions The “experimental” stroke service settings were those that provided “Integrated Stroke unit and Stroke services care” as defined by an expert consensus committee. Methodologically, the assessment of integrated stroke services is the evaluation of a complex mixture of interventions at the organizational, professional and patient levels. It needs careful definition, or at least a full description to allow for a transparent (cost-) effectiveness analysis. Formally, Dutch stroke services are defined as a network of service providers working together in an organized way to proved adequate services in all stages of the follow-up of stroke patients. It includes a hospital stroke unit. An expert group made this broad definition more explicit, defining a core set and an optimal set of criteria. It emphasizes a setting integrating all relevant institutions: hospitals, nursing homes, rehabilitation centers, general practitioners and home care providers working together to provide multidisciplinary, coordinated care through organized patient transfers and protocols. This definition is in accordance with international views.

We compared all consecutively hospitalized stroke patients in three experimental stroke service settings (Delft, Haarlem and Nijmegen, 411 patients in total) with concurrent patients receiving conventional stroke care (187 patients) over 6 months follow-up.
Primary outcome measure(s) 1. Health-related quality-of-life (QALIES) at two and six months
2. Cumulative total societal costs at three months (direct and indirect costs)
3. "Length-of-stay" as the most important cost driver
Secondary outcome measure(s) 1. Other neurological health outcomes (Glasgow Coma Scale, 30 item version of the Sickness Impact Profile [SA-SIP30], Cambridge Cognitive Examination, modified Rankin Scale [mRS], The Barthel Index [BI])
2. Care satisfaction
3. Indirect medical costs
4. Residence
5. Quality of care

A qualitative study also observed the characteristics of the regional services.
Sources of funding The Netherlands Organisation for Health Research and Development (ZonMw)
Trial website http://www.zonmw.nl
Publications 1. Results: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15879443
2. Results: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15528879
3. Results: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15473120
4. Results: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15085915
5. Results: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15053130
6. Results: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12773219
Contact name Prof  Robbert  Huijsman
  Address Inst Health Policy & Managment
Erasmus Unversity Rotterdam
Burgemeester Oudlaan 50
  City/town Rotterdam
  Zip/Postcode 3000DR
  Country Netherlands
  Tel +31 10 4088555
  Fax +31 10 4089093
  Email r.huijsman@erasmusmc.nl
Sponsor The Netherlands Organisation for Health Research and Development (ZonMw)
  Address Laan van Nieuw Oost Indië 334
Postbox 93 245
  City/town The Hague
  Zip/Postcode 2509 AE
  Country Netherlands
  Sponsor website: http://www.zonmw.nl/en/
Date applied 26/06/2007
Last edited 30/08/2011
Date ISRCTN assigned 26/07/2007
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central